AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JAMES HALSTEAD PLC

Interim / Quarterly Report Mar 31, 2021

7725_ir_2021-03-31_de44a29d-5137-424c-9f87-5abcd4192190.html

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0377U

James Halstead PLC

31 March 2021

31 March 2021

JAMES HALSTEAD PLC

INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2020

Key Figures

James Halstead plc, the AIM listed manufacturer and international distributor of commercial floor coverings, reports:

·    Revenue at £130.45 million (2019: £130.39 million) - level
·    Operating profit at £26.2 million (2019: £25.3 million) - up 3.9%
·    Pre-tax profit at £26.0 million (2019: £25.2 million) - up 3.3%
·    Basic earnings per ordinary share 9.8p (2019: 9.5p) - up 3.2%
·    Interim dividend declared of 4.25p
·    Cash at 31 December 2020 of £74.4 million

The Chief Executive, Mr. Mark Halstead, commented:

"I am very pleased to report these improved figures and all credit to our workforce for their efforts in the face of great uncertainty and major challenge. Trading continues to be solid".

Enquiries:

James Halstead:
Mark Halstead, Chief Executive Telephone: 0161 767 2500
Gordon Oliver, Finance Director
Hudson Sandler:
Nick Lyon Telephone: 020 7796 4133
Nick Moore
Panmure Gordon (NOMAD & Joint Broker):
Dominic Morley Telephone: 020 7886 2500
WH Ireland (Joint Broker):
Ben Thorne / Chris Hardie Telephone: 0207 220 1666

CHAIRMAN'S STATEMENT

Trading for the six months ended 31 December 2020

Our turnover of £130.45 million (2019: £130.39 million) shows a slight increase on the comparative six months. This is a record level for sales and, against a difficult global trading environment, a significant achievement. The variety of projects completed was, as ever, diverse from the Enigma Museum in Poznan, which has been built to commemorate the great success of three brilliant mathematicians - Marian Rejewski, Jerzy Różycki and Henryk Zygalski, to the Umm Al-Qura University in Mecca and the well known Canadian coffee retailer Second Cup in its Hemisphere Cannabis outlets.

Profit before tax of £26.0 million (2019: £25.2 million) is 3.3% ahead of the comparative period and is another record. Our cash inflows from operations in the period are £39.8 million. The business has performed well given the breadth of interruptions to many of our markets over the course of the six months.

In the UK our sales are 2.2% ahead of the prior comparative six months and are testament to the efforts of our sales and distribution teams in servicing the market. Sales across Europe were down 1% compared to the comparative period, Australasia showed positive growth of 2% and the rest of the world decreased 8%, the latter being principally adversely impacted by North America and the Middle East. Though commendable overall, it is evident that in many markets normal business has been significantly interrupted by the ongoing pandemic. 

Gross margins were resilient but were reduced and the factories were all affected by the operational difficulties of operating large-scale capital equipment with significant numbers of employees self-isolating and the associated employee safeguarding.

Overheads continue to be managed tightly and during the period there was little activity on new product launches due to the ongoing situation with Covid-19 and, in particular, the constraints on site visits and meeting customers. Historically there are major exhibitions to attend in the early part of the calendar year which have been cancelled with resulting cost savings relating to the usual expenditure on these events.

It is very encouraging that overall demand has been consistent through our first half year and in many markets was significantly higher than anticipated. Clearly normal business has been affected in areas such as retail and hospitality but others such as healthcare continue to be robust.  We have continued our long history of supplying flooring to healthcare projects globally from the Mahala Hospital in Gharbia Egypt, the Kopanong Regional Hospital in South Africa, St. Michael's Hospital in Toronto and the Haugesund hospital in Rogaland Norway.

Earnings per Share and Dividend

Our basic earnings per share at 9.8p is above the comparative period of 9.5p by 3.2%.

Our cash, which stands at £74.4 million compared with £64.3 million at 31 December 2019, continues to be a key strength.  The cash flow is helped by stock reduction in the period of some £6.5 million and whilst buoyant sales are to be welcomed, the reduction in stock levels has been due to the difficulty of operating our usual shift patterns as employees self-isolated. Ideally we would have looked to have about 7-8% higher stock at the end of the calendar year.

With regard to our cash and profitability we have decided to declare an interim dividend of 4.25p per share payable on 4 June 2021 to those shareholders on the register at the close of business on 7 May 2021. Last year as the first lockdown commenced we declared a first interim dividend of 2.125p paid on 5 June 2020 followed by a second interim, also of 2.125p, paid on 10 September 2020.

Having regard to our defined benefit pension scheme which is undergoing its triennial valuation the Company paid additional contributions of £2.0 million in August 2020. The reduction in retirement benefit obligations partly reflects these increased company contributions but also improved return on scheme assets and changes in demographic assumptions (including the effects of covid-19).

Environmental, sustainability, social responsibility and governance

Every two years we publish a full report on these topics to document and underline the Group's commitment to ESSG. As a manufacturer we see this as a key way of communicating our place in and contribution to society, and the many and varied actions that are ongoing inside the business. Whether it is the independent review of our supply chain or the verification of our products to the standards of indoor air quality or energy consumption we look always for credible, independent verification rather than "green marketing" labels. The latest report is published on our website and will be updated later this calendar year.

Environmental and sustainable business targets continue to be a key focus and in January 2021 our flooring ranges were re-certified to BES6001 (responsible sourcing) once again achieving the highest rating of "excellent". Just one example of our innovation: Even though our PVC flooring is incredibly durable and recyclable we have commenced the use of fossil free PVC polymers that are sourced from renewable biomass. This bio-vinyl does not take materials from the food chain and its manufacture has a 90% reduction in greenhouse gases when compared to traditional fossil fuel derived feedstock.

In terms of governance we, as a board, continue to believe in a straight forward approach to accounting and that a prudent and conservative attitude serves the Company and shareholders alike. Each year has its challenges and its successes and adjusting profit for the trials and tribulations of that year has not seemed appropriate to this board and for a capital intensive business adding back costs such as depreciation (by use of, for example,  EBITDA as a performance measure) is, we believe, to ignore an important charge on profit. Our key performance measures are turnover, profit before tax and cash generation.

Outlook

Post-Brexit trading began in January and though our exports are duty free into Europe there was considerable early disruption. There was confusion among freight forwarders, border control and customers alike and there were inescapable delays. Customers, in particular, were unprepared and confused by VAT procedures in their jurisdictions. The situation has improved considerably but there remain some issues such as EU sourced goods that are re-exported and attract import duty. The tumult in international sea freight noted in our Trading Update on 1 February 2021 has reduced but remains challenging.

We have recently supplied flooring to the Serum Institute of India in Pune for expansion of production of the Astra Zeneca AZD1222 vaccine and the ongoing roll out of the UK vaccination program offers the prospect of a high degree of normality returning to our home market and our production process. However, we operate in a global economy and the challenges of disruption continue in many regions. The situation in our biggest export market, Europe, remains under review as the Covid-19 virus continues to affect many countries with restrictions on movement of various degrees and duration. It remains the case that business is very far from normal. Another example is the "lightning" lockdown in Victoria, Australia during the Melbourne Open tournament which closed our facility in that state.

In recent months there have been shortages of basic raw materials that, in conjunction with employee absenteeism, have disrupted our production. There have been increases in the cost of materials which in themselves present challenges but availability is more problematical. These shortages, bordering on supplier rationing, continue but it is encouraging that production has been and continues to be able to fulfill all confirmed orders.

Having noted these adversities, demand remains consistently solid. Projects such as the new Macau Wholesale Market and the Van der Valk hotels in the Netherlands are just two examples of recent projects. We have continued confidence in the performance of our businesses in the second half of our financial year.

Anthony Wild

Chairman

31 March 2021

Consolidated Income Statement

for the half-year ended 31 December 2020

Half-year 

ended 

31.12.20 

£'000
Half-year 

ended 

31.12.19 

£'000
Year 

ended 

30.06.20 

£'000
Revenue 130,447 130,391 238,630
Operating profit 26,232 25,258 44,135
Finance income 33 243 382
Finance cost (277) (351) (660)
Profit before income tax 25,988 25,150 43,857
Income tax expense (5,639) (5,389) (9,502)
Profit for the period 20,349 19,761 34,355
Earnings per ordinary share of 5p:
-basic 9.8p 9.5p 16.5p
-diluted 9.8p 9.5p 16.5p

All amounts relate to continuing operations.

Details of dividends paid and declared/proposed are given in note 4.

Consolidated Balance Sheet

as at 31 December 2020

Half-year 

ended 

31.12.20 

£'000
Half-year 

ended 

31.12.19 

£'000
Year 

ended 

30.06.20 

£'000
Non-current assets
Property, plant and equipment 38,302 37,759 38,520
Right of use assets 7,799 7,103 5,872
Intangible assets 3,232 3,232 3,232
Deferred tax assets 2,568 3,179 4,334
51,901 51,273 51,958
Current assets
Inventories 61,861 67,180 68,542
Trade and other receivables 28,257 25,962 28,361
Derivative financial instruments 1,097 1,218 73
Cash and cash equivalents 74,445 64,332 67,445
165,660 158,692 164,421
Total assets 217,561 209,965 216,379
Current liabilities
Trade and other payables 54,006 50,643 47,444
Derivative financial instruments 1,791 290 883
Current income tax liabilities 1,461 740 773
Lease liabilities 3,496 2,774 2,568
60,754 54,447 51,668
Non-current liabilities
Retirement benefit obligations 13,446 19,354 23,216
Other payables 455 400 449
Lease liabilities 4,428 4,480 3,371
Preference shares 200 200 200
18,529 24,434 27,236
Total liabilities 79,283 78,881 78,904
Net assets 138,278 131,084 137,475
Equity
Equity share capital 10,407 10,407 10,407
Equity share capital (B shares) 160 160 160
10,567 10,567 10,567
Share premium account 4,072 4,044 4,072
Capital redemption reserve 1,174 1,174 1,174
Currency translation reserve 5,688 4,338 5,601
Hedging reserve (200) 225 (37)
Retained earnings 116,977 110,736 116,098
Total equity attributable to shareholders of the parent 138,278 131,084 137,475

Consolidated Cash Flow Statement

for the half-year ended 31 December 2020

Half-year 

ended 

31.12.20 

£'000
Half-year 

ended 

31.12.19 

£'000
Year 

ended 

30.06.20 

£'000
Profit for the period 20,349 19,761 34,355
Income tax expense 5,639 5,389 9,502
Profit before income tax 25,988 25,150 43,857
Finance cost 277 351 660
Finance income (33) (243) (382)
Operating profit 26,232 25,258 44,135
Depreciation of property, plant & equipment 1,738 1,650 3,185
Depreciation of right of use assets 1,485 1,487 2,937
Profit on sale of plant and equipment (34) (6) (43)
Defined benefit pension scheme service cost 245 318 611
Defined benefit pension scheme employer contributions paid (3,080) (1,074) (4,138)
Change in fair value of financial instruments (654) (344) 14
Share based payments 4 7 13
Decrease in inventories 6,488 1,044 1,717
(Increase)/decrease in trade and other receivables (865) 5,685 4,388
Increase/(decrease) in trade and other payables 8,286 (5,657) (10,450)
Cash inflow from operations 39,845 28,368 42,369
Taxation paid (4,520) (7,973) (11,566)
Cash inflow from operating activities 35,325 20,395 30,803
Purchase of property, plant and equipment (1,649) (2,479) (4,215)
Proceeds from disposal of property, plant and equipment 52 32 110
Cash outflow from investing activities (1,597) (2,447) (4,105)
Interest received 33 243 382
Interest paid (15) (11) (30)
Lease interest paid (82) (110) (202)
Lease capital paid (1,424) (1,335) (2,873)
Equity dividends paid (25,237) (20,813) (25,236)
Shares issued - - 28
Cash outflow from financing activities (26,725) (22,026) (27,931)
Net increase/(decrease) in cash and cash equivalents 7,003 (4,078) (1,233)
Effect of exchange differences (3) (254) 14
Cash and cash equivalents at start of period 67,445 68,664 68,664
Cash and cash equivalents at end of period 74,445 64,332 67,445

Consolidated Statement of Comprehensive Income

for the half-year ended 31 December 2020

Half-year 

ended 

31.12.20 

£'000
Half-year 

ended 

31.12.19 

£'000
Year 

ended 

30.06.20 

£'000
Profit for the period 20,349 19,761 34,355
Other comprehensive income net of tax:
Remeasurement of the net defined benefit liability 5,763 (247) (5,062)
Foreign currency translation differences 87 (927) 336
Fair value movements on hedging instruments (163) 246 (16)
Other comprehensive income for the period net of tax 5,687 (928) (4,742)
Total comprehensive income for the period 26,036 18,833 29,613
Attributable to equity holders of the parent 26,036 18,833 29,613

Notes to the Interim Results

for the half-year ended 31 December 2020

1. Basis of preparation
The interim financial statements are unaudited and do not constitute statutory accounts as defined within the Companies Act 2006.

The principal accounting policies applied in the preparation of the consolidated interim statements are those set out in the annual report and accounts for the year ended 30 June 2020.

The figures for the year ended 30 June 2020 are an abridged statement of the group audited accounts for that year. The financial statements for the year ended 30 June 2020 were audited and have been delivered to the Registrar of Companies.

As is permitted by the AIM rules, the directors have not adopted the requirements of IAS 34 'Interim Financial Reporting' in preparing the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.
2. Taxation
Income tax has been provided at the rate of 21.7% (2019: 21.4%).
3. Earnings per share
Half-year

ended

31.12.20

£'000
Half-year

ended

31.12.19

£'000
Year

ended

30.06.20

£'000
Profit for the period 20,349 19,761 34,355
Weighted average number of shares in issue 208,141,108 208,131,108 208,135,698
Dilution effect of outstanding share options 125,225 152,678 148,358
Diluted weighted average number shares 208,266,333 208,283,786 208,284,056
Basic earnings per 5p ordinary share 9.8p 9.5p 16.5p
Diluted earnings per 5p ordinary share 9.8p 9.5p 16.5p
4. Dividends
Half-year

ended

31.12.20

£'000
Half-year

ended

31.12.19

£'000
Year

ended

30.06.20

£'000
Equity dividends paid:
Final dividend for the year ended 30 June 2019 - 20,813 20,813
Interim dividend for the year ended 30 June 2020 4,423 - 4,423
Final dividend for the year ended 30 June 2020 20,814 - -
25,237 20,813 25,236
Equity dividends declared/proposed after the end of the period
Interim dividend 8,846 4,423 4,423
Final dividend - - 20,814

Equity dividends per share, paid and declared/proposed are as follows:

10.00p final dividend for the year ended 30 June 2019, paid on 6 December 2019

2.125p first interim dividend for the year ended 30 June 2020, paid on 5 June 2020

2.125p second interim dividend for the year ended 30 June 2020, paid 10 September 2020

10.00p final dividend for the year ended 30 June 2020, paid on 11 December 2020

4.25p interim dividend for the year ended 30 June 2021, payable on 4 June 2021, to those shareholders on the register at the close of business on 7 May 2021.
6. Copies of the interim results
Copies of the interim results have been sent to shareholders who requested them. Further copies can be obtained from the Company's registered office, Beechfield, Hollinhurst Road, Radcliffe, Manchester, M26 1JN and on the Company's website at www.jameshalstead.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IR SDSEFSEFSEED

Talk to a Data Expert

Have a question? We'll get back to you promptly.